Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia

Trends in Neurosciences

Volumn 20, Issue 10, 1997, Pages 482-487

  Ferré, Sergi ^a   Fredholm, Bertil B ^a   Morelli, Micaela ^b   Popoli, Patrizia ^c   Fuxe, Kjell ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR; DOPAMINE RECEPTOR;

BASAL GANGLION; DOPAMINERGIC TRANSMISSION; DRUG RECEPTOR BINDING; MOTOR SYSTEM; NERVE CELL NETWORK; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW;

EID: 0030861647     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(97)01096-5     Document Type: Article

References (48)

1. Ferré, S. et al. (1992) Neuroscience 51, 501-512
2. Gerfen, C.R. (1992) Trends Neurosci. 15, 133-139
3. Heimer, L., Alheid, G.F. and Zahm, D.S. (1993) in Limbic Motor Circuits and Neuropsychiatry (Kalivas, P.W. and Barnes, C.D., eds), pp. 1-43, CRC Press
4. Gingrich, J.A. and Caron, M.G. (1993) Annu. Rev. Neurosci. 16, 299-231
5. Yung, K. et al. (1995) Neuroscience 65, 709-730
6. Hersch, S.M. et al. (1995) J. Neurosci. 15, 5222-5237
7. Boyson, S.J., McGonigle, P. and Molinoff, P.B. (1986) J. Neurosci. 6, 3177-3188
8. Mengod, G. et al. (1991) Mol. Brain Res. 10, 185-191
9. Fox, C.A. et al. (1993) J. Chem. Neuroanat. 6, 363-373
10. Ferré, S. et al. (1996) Eur. J. Neurosci. 8, 1545-1553
11. Fredholm, B.B. (1995) Pharmacol. Toxicol. 76, 228-239
12. Jacobson, K.A. et al. (1993) Fed. Eur. Biochem. Soc. 336, 57-60
13. Alexander, S.P. and Reddington, M. (1989) Neuroscience 28, 645-651
14. Jin, S., Johansson, B. and Fredholm, B.B. (1993) J. Pharmacol. Exp. Ther. 267, 801-808
15. Fastbom, J., Pazos, A. and Palacios, J.M. (1987) Neuroscience 22, 813-826
16. Mahan, L.C. et al. (1991) Mol. Pharmacol. 40, 1-7
17. Mayfield, R.D. et al. (1996) Synapse 22, 132-138
18. Jarvis, M.F. and Williams, M. (1989) Eur. J. Pharmacol. 168, 243-246
19. Schiffmann, S.N., Jacobs, O. and Vanderhaeghen, J-J. (1991) J. Neurochem. 57, 1062-1067
20. Fink, J.S. et al. (1992) Mol. Brain Res. 14, 186-195
21. Brown, S.J. et al. (1990) J. Neurochem. 55, 31-38
22. Zoli, M. et al. (1993) Mol. Neurobiol. 7, 293-334
23. Ferré, S. et al. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 7237-7241
24. Ferré, S. and Fuxe, K. (1992) Brain Res. 594, 124-130
25. Ferré, S., Snaprud, P. and Fuxe, K. (1993) Eur. J. Pharmacol. 244, 311-315
26. Ferré, S. et al. (1994) Psychopharmacology 116, 279-284
27. Ferré, S. et al. (1994) NeuroReport 6, 73-76
28. Dasgupta, S. et al. (1996) Eur. J. Pharmacol. 316, 325-331
29. Yang, S-N. et al. (1995) Neuroscience 68, 729-736
30. Abbracchio, M.P. et al. (1987) Pharmacol. Res. Commun. 19, 275-286
31. Parsons, B. et al. (1995) J. Neurochem. 65, 2057-2064
32. Robertson, G.S., Vincent, S.R. and Fibiger, H.C. (1992) Neuroscience 49, 285-296
33. Pollack, A.E. and Fink, J.S. (1995) Neuroscience 68, 721-728
34. Konradi, C. and Heckers, S. (1995) Neuroscience 65, 1051-1061
35. Boegman, R.J. and Vincent, S.R. (1996) Synapse 22, 70-77
36. Morelli, M. et al. (1995) Neuroscience 67, 49-55
37. Svenningsson, P., Nomikos, G.G. and Fredholm, B.B. (1995) J. Neurosci. 15, 7612-7624
38. Svenningsson, P. et al. Neuroscience (in press)
39. Ferré, S. et al. (1993) J. Neurosci. 13, 5402-5406
40. Kurokawa, M. et al. (1994) Br. J. Pharmacol. 113, 43-48
41. Mori, A. et al. (1996) J. Neurosci. 16, 605-611
42. Kurokawa, M. et al. (1996) J. Neurochem. 66, 1882-1888
43. Vellucci, S.V., Sirinathsinghji, D.J.S. and Richardson, P.J. (1993) Psychopharmacology 111, 383-388
44. Popoli, P., Pèzzola, A. and Scotti de Carolis, A. (1994) Eur. J. Pharmacol. 257, 21-25
45. Pinna, A. et al. (1996) Eur. J. Neurosci. 8, 1176-1181
46. Popoli, P. et al. (1996) Neurosci. Lett. 218, 209-213
47. Fenu, S. et al. Eur. J. Pharmacol. (in press)
48. Mally, J. and Stone, T.W. (1994) J. Pharm. Pharmacol. 46, 515-517